Pharma Times

JULY 12, 2024

The serious, rare condition is responsible for up to 7% of all neonatal deaths globally

Development 115

Development Research 115

Bio Pharma Dive

JULY 12, 2024

Patent litigation has opened the door to generic copies of Bristol Myers’ Sprycel arriving in the U.S. as soon as September.

299

299

Pharmaceutical Technology

JULY 12, 2024

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

279

279

Bio Pharma Dive

JULY 12, 2024

Sales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing an ADC and Novartis is closing a San Diego site.

Sales 182

Sales Licensing Licensing Drugs 182

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

JULY 12, 2024

Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.

Licensing 246

Licensing Licensing 246

Fierce Pharma

JULY 12, 2024

Trials have already shown that Novo Nordisk’s semaglutide | Trials have already shown that Novo Nordisk’s semaglutide can cut the risk of cardiovascular events and kidney disease. Now a study from the University of Oxford indicates that the company’s semaglutide type 2 diabetes drug Ozempic can reduce the risk of dementia compared with another popular diabetes medicine.

Trials 128

Trials Medicine Drugs 128

Pharma Times

JULY 12, 2024

The progressive neurodegenerative disease affects more than 55 million people globally

123

123

Pharmaceutical Technology

JULY 12, 2024

Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.

Development 147

Development 147

Pharma Times

JULY 12, 2024

The awards celebrated both medical affairs and nursing professionals in the industry

Nurses 120

Nurses 120

Pharmaceutical Technology

JULY 12, 2024

MSD (Merck & Co) plans to start a Phase IIb/III trial for EyeBio’s lead candidate, Restoret, in diabetic macular oedema in H2.

Trials 130

Trials 130

Advertisement

Clinical Supply

pharmaphorum

JULY 12, 2024

A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.

Behavioural Health 119

Behavioural Health 119

Pharmaceutical Technology

JULY 12, 2024

As Wes Streeting takes over the UK’s Department for Health and Social care, investors wait to see if the Labour government will will do.

130

130

Fierce Pharma

JULY 12, 2024

Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the future—despite a few promising growth opportunities the team has identified. | Several challenges across Bristol Myers Squibb’s business have Leerink Partners analysts worried about the drugmaker—despite a few promising growth opportunities they identified.

Production 115

Production 115

Pharmaceutical Technology

JULY 12, 2024

Bayer and Asklepios BioPharmaceutical (AskBio) have announced FDA fast track designation for AB-1005, a gene therapy for PD.

Gene Therapy 130

Gene Therapy Gene 130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

pharmaphorum

JULY 12, 2024

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

DNA 111

DNA Marketing 111

Pharmaceutical Technology

JULY 12, 2024

Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of preclinical studies for its leading product, PCT1:CO-STIM.

Production 130

Production 130

Fierce Pharma

JULY 12, 2024

Even through an onslaught of biosimilar launches that began early last year, AbbVie’s big-selling Humira has been able to retain most of its lucrative market. | With ten biosimilar options in play, AbbVie's star immunology drug lost 13% of its total market share since March, according to a new Samsung Bioepis report.

Marketing 110

Marketing Drugs 110

pharmaphorum

JULY 12, 2024

Stay informed about the upcoming EU Artificial Intelligence Act, which will regulate AI use in compliance with EU standards. Learn how this legislation may impact your organisation's AI initiatives.

Compliance 110

Compliance Regulation 110

Advertisement

Clinical Supply

Pharmaceutical Commerce

JULY 12, 2024

The latest news for pharma industry insiders.

Vaccine 105

Vaccine Vaccination 105

pharmaphorum

JULY 12, 2024

Learn how to effectively connect the clinical, regulatory, and commercial aspects in the development of treatments for rare diseases. Discover strategies and insights for navigating the unique challenges of rare disease drug development.

Development 106

Development Drugs 106

BioSpace

JULY 12, 2024

The Senate on Thursday unanimously passed a bill aimed at limiting the number of patents drugmakers can introduce and making it easier for generic and biosimilar competitors to enter the market.

Marketing 100

Marketing 100

pharmaphorum

JULY 12, 2024

New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it

105

105

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Fierce Pharma

JULY 12, 2024

With a new production line up and running at its latest facility in the greater Boston area, family-owned German CDMO Rentschler Biopharma is eager to court new clients. | Rentschler this week revealed that the production line at its site in Milford, Massachusetts (formerly known as the Rentschler Biopharma Manufacturing Center), is now fully operational.

Production 97

Production Manufacturing 97

pharmaphorum

JULY 12, 2024

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.

Drugs 104

Drugs 104

Drug Channels

JULY 12, 2024

Today’s guest post comes from Gavin Magaha, Senior Director of External Affairs and Policy at Kalderos. Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. He then explains Oregon’s novel approach to fixing the problem. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail.

Drugs 94

Drugs 94

BioSpace

JULY 12, 2024

Akebia Therapeutics on Thursday said it regained full U.S. rights to its chronic kidney disease anemia drug Vafseo, which the biotech has priced at around $15,500 per year.

Drugs 81

Drugs 81

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

BioPharma Reporter

JULY 12, 2024

On June 24, Novo Nordisk revealed plans for a $4.1 billion investment in a new manufacturing facility in Clayton, North Carolina.

Manufacturing 76

Manufacturing Contract Manufacturing 76

BioSpace

JULY 12, 2024

CVS Caremark’s recent decision to take AbbVie’s Humira off its major formularies has caused the blockbuster to lose more market share to biosimilars, according to the latest report from Samsung Bioepis.

Marketing 80

Marketing 80

Outsourcing Pharma

JULY 12, 2024

Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceutical manufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.

Packaging 75

Packaging Packaging Manufacturing Production 75

BioSpace

JULY 12, 2024

Immutep shares jumped nearly 20% on Friday after data showed its LAG-3 therapy—plus Keytruda—elicited strong response rates in head and neck squamous cell carcinoma patients in the front-line setting.

67

67

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials